Comparative effectiveness of infliximab and tofacitinib in advanced therapy-naive and -exposed patients with ulcerative colitis: a multicenter real-world study
- DOI
- 10.1093/ibd/izag248
- Published
- 2026-11-10
- Container
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ibd/izag248,
title = {Comparative effectiveness of infliximab and tofacitinib in advanced therapy-naive and -exposed patients with ulcerative colitis: a multicenter real-world study},
author = {Noboru Mizuta and Naohiko Kinoshita and Kazuki Kakimoto and Azusa Hara and Hiroaki Ito and Hitoshi Hongo and Kei Moriya and Keijiro Numa and Kei Nakazawa and Ryoji Koshiba and Yuki Hirata and Takako Miyazaki and Shiro Nakamura and Hiroki Nishikawa},
year = {2026},
journal = {Inflammatory Bowel Diseases},
doi = {10.1093/ibd/izag248},
url = {https://doi.org/10.1093/ibd/izag248}
}RIS
TY - JOUR TI - Comparative effectiveness of infliximab and tofacitinib in advanced therapy-naive and -exposed patients with ulcerative colitis: a multicenter real-world study AU - Noboru Mizuta AU - Naohiko Kinoshita AU - Kazuki Kakimoto AU - Azusa Hara AU - Hiroaki Ito AU - Hitoshi Hongo AU - Kei Moriya AU - Keijiro Numa AU - Kei Nakazawa AU - Ryoji Koshiba AU - Yuki Hirata AU - Takako Miyazaki AU - Shiro Nakamura AU - Hiroki Nishikawa PY - 2026 JO - Inflammatory Bowel Diseases DO - 10.1093/ibd/izag248 UR - https://doi.org/10.1093/ibd/izag248 ER -
APA
Mizuta, N., Kinoshita, N., Kakimoto, K., Hara, A., Ito, H., Hongo, H., Moriya, K., Numa, K., Nakazawa, K., Koshiba, R., Hirata, Y., Miyazaki, T., Nakamura, S., & Nishikawa, H. (2026). Comparative effectiveness of infliximab and tofacitinib in advanced therapy-naive and -exposed patients with ulcerative colitis: a multicenter real-world study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag248
Source records
- crossref · retrieved 2026-11-10T18:00:44.226Z